Jennifer Schlaufman Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1540 Cowpath Rd, Hatfield, PA 19440 Phone: 215-412-9264 |
Carolyn Bacica-fahey Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1530 Cowpath Rd, Hatfield, PA 19440 Phone: 215-361-2542 Fax: 215-361-2631 |
Susan Ann Cruciani Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1540 Cowpath Rd, Hatfield, PA 19440 Phone: 215-412-9264 Fax: 215-412-9260 |
Mr. William Joseph Discavage Iii Pharmacist - Critical Care Medicare: Not Enrolled in Medicare Practice Location: 1515 Bethlehem Pike # 2445, Hatfield, PA 19440 Phone: 215-997-1670 |
Keith Avery Robak, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1540 Cowpath Rd, Hatfield, PA 19440 Phone: 215-412-9264 |
Susan Lynne Schramm-apple Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1515 Bethlehem Pike, Hatfield, PA 19440 Phone: 215-997-1670 |
Steven James Devane Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1515 Bethlehem Pike, Hatfield, PA 19440 Phone: 215-896-7903 |
Andrew R Taylor Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1072 Independence Way, Hatfield, PA 19440 Phone: 215-822-7499 |
Michelle Qing Jiang Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1515 Bethlehem Pike, Hatfield, PA 19440 Phone: 215-997-1670 |
Heng M Tran Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1500 Industry Rd, Hatfield, PA 19440 Phone: 800-879-4471 |
Tejal Nast Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1530 Cowpath Rd, Hatfield, PA 19440 Phone: 267-664-2061 |
Parthiv Patel, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1515 Bethlehem Pike, Hatfield, PA 19440 Phone: 215-997-1670 |
News Archive
The brain centers triggered by a betrayal of trust have been identified by researchers, who found they could suppress such triggering and maintain trust by administering the brain chemical oxytocin. The researchers said their findings not only offer basic insights into the neural machinery underlying trust; the results may also help in understanding the neural basis of social disorders such as phobias and autism.
More than a quarter of HIV+ patients are also infected with the Hepatitis C virus (HCV), which may complicate treatment and care decisions after a cancer diagnosis. The specifics of those complications haven't been well-researched in the past. Results from a new Fox Chase Cancer Center study on this patient population may start filling in that gap.
PSR announced today the launch of its new service and dedicated website, OrphanIQ. OrphanIQ is a quick and easy way for companies involved in Orphan Drug development to ask a short question on a variety of topics without the need for setting up time-consuming agreements and contracts. Questions will be handled by the relevant expert, who will first assess whether the question can be answered without obtaining further information, and within a reasonable time-frame, and will subsequently provide a written answer.
Genomic Health, Inc. today announced worldwide commercial availability of its Oncotype DX® colon cancer test, the first multigene expression test developed for the assessment of risk of recurrence in patients with stage II disease. The 12-gene advanced diagnostic test is clinically validated to predict individual recurrence risk in stage II colon cancer patients following surgery, as reported at the 2009 American Society of Clinical Oncology (ASCO) meeting.
As a result of the health law, many early retirees may in 2014 be eligible for Medicaid, the federal-state health insurance program for the poor. This expansion, which is being termed a "glitch" and is drawing significant Republican reaction, could mean that early retirees with household incomes up to $64,000 would qualify.
› Verified 6 days ago